NeoAB-33

N/A

Report date: 2025/07/01 11:03:27

Base Information

Drug NameNeoAB-33
Drug Alias NameNeoAB33
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsDiabetic peripheral neuropathyIschemic StrokeDiabetic Nephropathies +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesBeijing Protein Innovation
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesBeijing Protein InnovationBeijing Science Sun Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsDiabetic peripheral neuropathyIschemic StrokeDiabetic Nephropathies +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A